AGER-Mediated Lipid Peroxidation Drives Caspase-11 Inflammasome Activation in Sepsis

Ruochan Chen,Shan Zhu,Ling Zeng,Qingde Wang,Yi Sheng,Borong Zhou,Daolin Tang,Rui Kang
DOI: https://doi.org/10.3389/fimmu.2019.01904
IF: 7.3
2019-08-08
Frontiers in Immunology
Abstract:Inflammasome activation can trigger an inflammatory and innate immune response through the release of cytokines and induction of pyroptosis. A dysfunctional inflammasome has been implicated in the development of human pathologies, including sepsis and septic shock. Here, we show that advanced glycosylation end-product specific receptor (AGER/RAGE) is required for caspase-11 inflammasome activation in macrophages. A nuclear damage-associated molecular pattern (nDAMP) complex, including high-mobility group box 1, histone, and DNA, can promote caspase-11-mediated gasdermin D cleavage, interleukin 1β proteolytic maturation, and lactate dehydrogenase release. The inhibition of AGER-mediated lipid peroxidation via arachidonate 5-lipoxygenase (ALOX5) limits caspase-11 inflammasome activation and pyroptosis in macrophages in response to nDAMPs or cytosolic lipopolysaccharide. Importantly, the pharmacologic inhibition of the AGER-ALOX5 pathway or global depletion (<i>Ager</i><sup>−/−</sup>) or conditional depletion of <i>AGER</i> in myeloid cells (<i>Ager</i><sup><i>Mye</i>−/−</sup>) protects against lipopolysaccharide-induced septic death in poly(I:C)-primed mice. These data identify a molecular basis for caspase-11 inflammasome activation and provide a potential strategy to treat sepsis.
immunology
What problem does this paper attempt to address?